Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
FREMONT, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”)…
News
Viracta Therapeutics to Present at the 2023 SVB Securities Global Biopharma Conference
SAN DIEGO, Feb. 07, 2023 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision…
MediWound Announces Closing of $27.5 Million Registered Direct Offering of Ordinary Shares
YAVNE, Israel, Feb. 07, 2023 (GLOBE NEWSWIRE) — MediWound Ltd. (NASDAQ: MDWD), a fully integrated biopharmaceutical…
Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC
CFIUS clearance represents the final required regulatory approval to complete the proposed merger Completion remains…
Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares
SAN FRANCISCO and SHANGHAI, Feb. 07, 2023 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR),…
Verizon waives calling charges to Turkey and in-country roaming charges
Verizon Wireless customers can call to Turkey for free BASKING RIDGE, N.J., Feb. 07, 2023…
Basra Sky Completes Historic Export of VGO from Iraq
Basra, Iraq–(Newsfile Corp. – February 7, 2023) – Basra Sky Oil & Gas Service made history…
DCS Announces Expected Uplist to the NYSE American Stock Exchange and Reverse Stock Split
San Diego, California–(Newsfile Corp. – February 7, 2023) – Direct Communication Solutions, Inc. (OTCQX: DCSX) (CSE:…
Dusit International appoints Makoto Yamashita to spearhead Kyoto, Japan hotel openings
BANGKOK & KYOTO, Japan, Feb 8, 2023 – (JCN Newswire) – Dusit International, one of…
Aurora Acquisition Corp. Announces Filing of a Definitive Proxy Statement for a Shareholder Meeting on February 24, 2023
NEW YORK–(BUSINESS WIRE)–Aurora Acquisition Corp. (NASDAQ: AURC) (“Aurora” or “the Company”), a publicly traded special…
Nerdy to Announce Fourth Quarter and Full Year 2022 Results on February 28, 2023
ST. LOUIS–(BUSINESS WIRE)–Nerdy Inc. (NYSE: NRDY), a leading platform for delivering live online learning, today…
Atmos Energy Corporation Reports Earnings for Fiscal 2023 First Quarter; Affirms Fiscal 2023 Guidance
DALLAS–(BUSINESS WIRE)–Atmos Energy Corporation (NYSE: ATO) today reported consolidated results for its first fiscal quarter…
Concert Health Co-founder and Chief Clinical Officer to Testify in Maryland in Support of Integrated Behavioral Health Expansion Through Collaborative Care
Dr. Virna Little, PsyD, LCSW-r of Concert Health is testifying in support of Maryland House…
Westlake Financial Remarketing Division Presents the 2022 Auction of the Year Award to Rawls Auto Auction
LOS ANGELES–(BUSINESS WIRE)–Westlake Financial Remarketing division is thrilled to announce the winner of its 2022…
MicroEJ and Schneider Electric Accelerate the Software-Defined Energy Infrastructure
MicroEJ and Schneider Electric leverage software containerization to redefine energy systems and expand opportunities in…
Store Space Hires JC Reed, Formerly of Public Storage, as VP of Ops
WINTER GARDEN, Fla.–(BUSINESS WIRE)–Store Space Self Storage is proud to announce hiring JC Reed as…
Fabric Introduces the Partner Elite Program to Reshape Retail Fulfillment
Program provides resources and support tailored to system integrators, referral partners and OEMs New Global…
Even More Homeowners Eligible for Assistance With Mortgage Costs as California Mortgage Relief Program Expands
SACRAMENTO, Calif.–(BUSINESS WIRE)–After successfully distributing nearly $300 million in assistance to eligible homeowners statewide, the…
Textron Aviation Adds to Growing List of Options for Cessna SkyCourier With Introduction of New Gravel Kit
WICHITA, Kan.–(BUSINESS WIRE)–Textron Aviation today announced it is now offering a gravel kit for its…
Osteal Therapeutics Announces First Subject Enrollment in Second Phase 2 Clinical Trial of VT-X7 Combination Product for Treatment of Periprosthetic Joint Infection
The second Phase 2 clinical trial known as APEX-2 will augment the VT-X7 safety and…